Neuroinflammation in fetal alcohol spectrum disorders and related novel therapeutic approaches

Biochim Biophys Acta Mol Basis Dis. 2024 Jan;1870(1):166854. doi: 10.1016/j.bbadis.2023.166854. Epub 2023 Aug 21.

Abstract

Fetal alcohol spectrum disorders (FASD) is an umbrella term to describe the neurological effects of prenatal alcohol exposure (PAE). It has been extensively characterized that PAE causes cell proliferation disruption, heterotopias, and malformations in various brain regions and there is increasing evidence that neuroinflammation is responsible for some of these neurotoxic effects. Despite evidence of its importance, neuroinflammation is not usually considered at diagnosis or treatment for FASD. Here, we discuss the literature regarding anti- inflammatory drugs and nutraceuticals, which hold promise for future therapeutical interventions in these disorders.

Keywords: Apelin-13; Cannabidiol; Curcumin; FASD; Neuroinflammation; Nutraceutical; Omega-3.

Publication types

  • Review

MeSH terms

  • Female
  • Fetal Alcohol Spectrum Disorders* / therapy
  • Humans
  • Neuroinflammatory Diseases
  • Pregnancy
  • Prenatal Exposure Delayed Effects*